Xenetic Biosciences logo
Xenetic Biosciences XBIO
$ 3.81 1.6%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

Xenetic Biosciences Balance Sheet 2011-2024 | XBIO

Annual Balance Sheet Xenetic Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - -11.5 M -10.4 M -572 K -5.53 M -4.05 M 263 K -2.11 M 160 K 181 K 203 K

Long Term Debt

- - - - - - - - - - 213 K 213 K 213 K

Long Term Debt Current

- - - - - - - - - - - - -

Total Non Current Liabilities

- - - 27 K 2.92 M 2.92 M 2.92 M 2.94 M 2.96 M 3.14 M 213 K 213 K 213 K

Total Current Liabilities

810 K 1.07 M 1.42 M 937 K 1.42 M 1.6 M 1.94 M 1.87 M 7.34 M 2.7 M 3.59 M 1.4 M -

Total Liabilities

810 K 1.07 M 1.42 M 964 K 4.33 M 4.52 M 4.86 M 4.8 M 10.3 M 5.84 M 669 K 417 K 221 K

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-193 M -189 M -183 M -177 M -166 M -153 M -146 M -142 M -88.1 M -75.6 M -317 K -138 K -8.24 K

Total Assets

10.6 M 14.7 M 19.8 M 13.2 M 21.5 M 14.4 M 19.2 M 21 M 16.9 M 16.3 M 487 K 324 K 222 K

Cash and Cash Equivalents

8.98 M 13.1 M 18.2 M 11.5 M 10.4 M 572 K 5.53 M 4.05 M 132 K 2.51 M 4.84 M 11.1 M 17.1 M

Book Value

9.8 M 13.6 M 18.4 M 12.2 M 17.2 M 9.91 M 14.3 M 16.2 M 6.61 M 10.5 M -182 K -92.9 K 1.76 K

Total Shareholders Equity

9.8 M 13.6 M 18.4 M 12.2 M 17.2 M 9.91 M 14.3 M 16.2 M 6.61 M 10.5 M 12.6 M 20.8 M 14.8 M

All numbers in USD currency

Quarterly Balance Sheet Xenetic Biosciences

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - 7.96 K 17.6 K 27 K - - - - - - - - - - - - - - - - 213 K - - - - - - - - - - - 213 K 213 K 213 K 213 K 213 K 213 K 213 K - 213 K 213 K -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

1.59 M 716 K 810 K 1.07 M 871 K 856 K 1.07 M 1.05 M 1.28 M 1.06 M 1.42 M 1.12 M 966 K 816 K 964 K 964 K 964 K 964 K 4.33 M 4.33 M 4.33 M 4.33 M 4.52 M 4.52 M 4.52 M 4.52 M 4.86 M 4.86 M 4.86 M 4.86 M 4.8 M 4.8 M 4.8 M 4.8 M 10.3 M 10.3 M 10.3 M 10.3 M 5.84 M 5.84 M 5.84 M 5.84 M 6.85 M 6.85 M 6.85 M 6.85 M 4.59 M 417 K 417 K 459 K - 221 K - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-196 M -194 M -193 M -192 M -191 M -190 M -189 M -188 M -187 M -184 M -183 M -181 M -179 M -178 M -177 M -177 M -177 M -177 M -166 M -166 M -166 M -166 M -153 M -153 M -153 M -153 M -146 M -146 M -146 M -146 M -142 M -142 M -142 M -142 M -88.1 M -88.1 M -88.1 M -88.1 M -75.6 M -75.6 M -75.6 M -75.6 M -58.3 M -58.3 M -58.3 M -58.3 M -49.7 M -228 K - - - - - -

Total Assets

9.03 M 9.39 M 10.6 M 12 M 12.7 M 13.7 M 14.7 M 15.6 M 16.5 M 18 M 19.8 M 21.3 M 10.9 M 11.8 M 13.2 M 13.2 M 13.2 M 13.2 M 21.5 M 21.5 M 21.5 M 21.5 M 14.4 M 14.4 M 14.4 M 14.4 M 19.2 M 19.2 M 19.2 M 19.2 M 21 M 21 M 21 M 21 M 16.9 M 16.9 M 16.9 M 16.9 M 16.3 M 16.3 M 16.3 M 16.3 M 19.5 M 19.5 M 19.5 M 19.5 M 25.4 M 324 K 324 K 352 K - 222 K 222 K -

Cash and Cash Equivalents

7.3 M 7.82 M 8.98 M 9.78 M 10.7 M 12 M 13.1 M 13.8 M 14.9 M 16.2 M 18.2 M 19.7 M 9.28 M 10 M 11.5 M 11.5 M 11.5 M 11.5 M 10.4 M 10.4 M 10.4 M 10.4 M 572 K 572 K 572 K 572 K 5.53 M 5.53 M 5.53 M 5.53 M 4.05 M 4.05 M 4.05 M 4.05 M 132 K 132 K 132 K 132 K 2.51 M 2.51 M 2.51 M 2.51 M 4.84 M 4.84 M 4.84 M 4.84 M 11.1 M 32 K 32 K 32 K 17.1 M 10 K 10 K -

Book Value

7.45 M 8.68 M 9.8 M 10.9 M 11.9 M 12.9 M 13.6 M 14.5 M 15.2 M 16.9 M 18.4 M 20.2 M 9.95 M 10.9 M 12.2 M 12.2 M 12.2 M 12.2 M 17.2 M 17.2 M 17.2 M 17.2 M 9.91 M 9.91 M 9.91 M 9.91 M 14.3 M 14.3 M 14.3 M 14.3 M 16.2 M 16.2 M 16.2 M 16.2 M 6.61 M 6.61 M 6.61 M 6.61 M 10.5 M 10.5 M 10.5 M 10.5 M 12.6 M 12.6 M 12.6 M 12.6 M 20.8 M -92.9 K -92.9 K -107 K - 1.76 K 222 K -

Total Shareholders Equity

7.45 M 8.68 M 9.8 M 10.9 M 11.9 M 12.9 M 13.6 M 14.5 M 15.2 M 16.9 M 18.4 M 20.2 M 9.95 M 10.9 M 12.2 M 12.2 M 12.2 M 12.2 M 17.2 M 17.2 M 17.2 M 17.2 M 9.91 M 9.91 M 9.91 M 9.91 M 14.3 M 14.3 M 14.3 M 14.3 M 16.2 M 16.2 M 16.2 M 16.2 M 6.61 M 6.61 M 6.61 M 6.61 M 10.5 M 10.5 M 10.5 M 10.5 M 12.6 M 12.6 M 12.6 M 12.6 M 20.8 M -92.9 K -92.9 K -107 K 14.8 M -92.9 K 1.76 K -

All numbers in USD currency